Stock CCEL CRYO-CELL INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cryo-Cell International, Inc.

Equities

CCEL

US2288951088

Market Closed - Nyse
Other stock markets
 04:10:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
8.57 USD +3.38% Intraday chart for Cryo-Cell International, Inc. +9.87% +49.04%
Apr. 15 Cryo-Cell International, Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
Mar. 25 Cryo-Cell International to Spin Off Celle Unit, Explore Strategic Alternatives; Shares Jump MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Weaknesses

  • The company has insufficient levels of profitability.
  • With an expected P/E ratio at 285.67 and 71.42 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
CRYO-CELL INTERNATIONAL, INC. Stock Cryo-Cell International, Inc.
+49.04% 67.19M -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.10% 81.84B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-30.15% 70.69B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 29.03B
C+
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.90% 16.97B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.36% 16.83B
A-
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-1.12% 15.28B
A-
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+5.90% 12.41B
A-
DAVITA INC. Stock DaVita Inc.
+35.78% 12.26B
B-
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-4.20% 11.86B
A-
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. CCEL Stock
  4. Ratings Cryo-Cell International, Inc.